Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)

Read more

Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies

Read more

Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics

Read more

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Read more

Calquence approved in China for chronic lymphocytic leukaemia

Read more

GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps

Read more

AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

Read more

7th IPF Summit: Advancing Insights and Collaboration in Pulmonary Fibrosis Research and Therapeutic Development

Read more

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

Read more

Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases

Read more

Posts pagination

Previous Page 1 of 923 … Page 150 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version